|
|
|
|
|
by dougweltman
2056 days ago
|
|
>Early on, one person got symptoms consistent with typical vaccine side effects, but it was determined that the person had a previously undiagnosed, unrelated disease. Second, there was the highly publicized case where a patient suffered temporary spinal inflammation and recovered shortly. It is unclear if this event is related to the vaccine, ... This seems rather worrying as these Phase 1 and Phase 2 trials are pretty small, no? What are the odds these patients got this from the vaccine vs whatever else they had going on? I just can't shake the fact that this particular vaccine seems to have some safety issues. We'll see in Phase 3 if this shakes out, but I would like to understand why governments feel safe about these developments. |
|